Albrecht Stöffler

Memantine in Moderate-to-Severe Alzheimer's Disease

‌Barry Reisberg, Rachelle S. Doody, Albrecht Stöffler et al. · New England Journal of Medicine · 2003 · 2K citations · Full text

Efficacy and Safety of Memantine in Patients With Mild to Moderate Vascular Dementia

Jean‐Marc Orgogozo, Anne‐Sophie Rigaud, Albrecht Stöffler et al. · Stroke · 2002 · 535 citations

Neuroprotective and symptomatological action of memantine relevant for alzheimer’s disease — a unified glutamatergic hypothesis on the mechanism of action

Wojciech Danysz, Chris G. Parsons, Hans Jörg Möbius et al. · Neurotoxicity Research · 2000 · 262 citations

Neurodegenerative Diseases, Unified Glutamatergic Hypothesis, Neurobiology Of Disease +13

A 24-Week Open-Label Extension Study of Memantine in Moderate to Severe Alzheimer Disease

‌Barry Reisberg, Rachelle S. Doody, Albrecht Stöffler et al. · Archives of Neurology · 2006 · 180 citations

Resource Utilisation and Cost Analysis of Memantine in Patients with Moderate to Severe Alzheimer??s Disease

Anders Wimo, Bengt Winblad, Albrecht Stöffler et al. · PharmacoEconomics · 2003 · 166 citations

Alzheimer's Disease, Geriatrics, Dementia +11